Even when forced online by the pandemic, music therapy sessions continue to help patients in some ways talk therapy can't. "Music is this portal," says one therapist and COVID-19 long-hauler.

Lab-grown brainlike organoids altered with an ancient gene began to look and behave differently. The experiments help show how the human brain has evolved.

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

Supply shortages of oxygen for hospitals have plagued many countries, but the U.S. has averted the most dire — partly because the industry figured out new ways to share resources and anticipate needs.

The spread of new strains raises new questions as two COVID-19 vaccines continue their rollout across the U.S. and another vaccine candidate preps for regulatory review. Here's what you need to know.

Large corporations such as Starbucks, Honeywell, Microsoft, Costco and Google want to help states with planning and logistics. But the potential of these partnerships is hindered by supply problems.

As COVID-19 vaccines roll out, doctors say it's long past time to address the exclusion of pregnant women from research on drugs and vaccines. They say better study design is the answer.

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Two studies find that tailoring brain stimulation to a particular patient helps in treating depression and obsessive-compulsive behaviors.

The evidence is strong that some people struggling with meth addiction benefit from the drug regime.

Antibody-based drugs that bind to the coronavirus to prevent it from invading cells can help patients with mild to moderate COVID-19. But the medicines can be tough to find in time.

With case and death counts still surging, the pressure is on to vaccinate as many people as possible. Here's what it will take to get more Americans their shots, fast.

While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.

Severe cases of COVID-19 can injure the brain in ways that affect memory, thinking and mood for months after the infection is gone, new research hints. It may even raise the risk of Alzheimer's.

Boston Children's Hospital saw a precipitous drop in cases during the spring shutdown, and the trend continues. Researchers are asking why — and what it would take to keep up the change post-pandemic.